Covid-19 vaccine: Pfizer aiming for 50 million doses in next eight weeks

Initial clinical trial results show that the Covid-19 vaccine is 90% effective at preventing illness. Picture: Reuters

Pharmaceutical giant Pfizer is hoping to produce 50m doses before year-end of a new Covid-19 vaccine that has been shown to be 90% effective at preventing illness, according to initial clinical trial results released on Monday.

Pfizer and German drugmaker BioNTech have taken the lead in the international race to find a vaccine against Covid-19 as they released preliminary clinical trial results.